Zentalis Pharmaceuticals Llc
ZNTL
$3.13-10.57%
End of day · as of Sep 16, 2026, 3:45 AM ET
Mkt cap
$257.69M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (TTM)
$-1.96
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported ZNTL revenue for 2025-12-31 was $0. Net income was -$137.1M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ZNTL currently screens at market cap $257.7M.
Use this ZNTL research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ZNTL income, balance, and cash tables.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company in the Healthcare sector.
Latest cached Zentalis Pharmaceuticals Llc (ZNTL) net income for Dec 31, 2025 was -$137.1M. Statements: https://lician.com/financials/zntl
Zentalis Pharmaceuticals Llc (ZNTL) market capitalization is $257.7M on the latest cached snapshot.
Zentalis Pharmaceuticals Llc (ZNTL) cached previous close $3.50; day range $3.12 – $3.51; volume 1,397,927. Session quote: https://lician.com/quote/zntl